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Aggregation of human ɲ-synuclein (ɲSyn) is linked to Parkinsons disease (PD) pathology. The central 20 
region of the ɲSyn sequence contains the non-amyloid β-component (NAC) crucial for aggregation. 21 
However, how NAC flanking regions modulate ɲSyn aggregation remains unclear. Using 22 
bioinformatics, mutation, and NMR we identify a 7-residue sequence, named P1 (residues 36-42), 23 
that controls ɲSyn aggregation. Deletion or substitution of this master-controller prevents 24 
aggregation at pH 7.5 in vitro. At lower pH, P1 synergises with a sequence containing the PreNAC 25 
region (P2, residues 45-57) to prevent aggregation. Deleting P1 (ΔP1) or both P1 and P2 (ΔΔ) also 26 
prevents age-dependent ɲSyn aggregation and toxicity in C. elegans models and prevents αSyn-27 
mediated vesicle fusion by altering the conformational properties of the protein when lipid-bound. 28 
The results highlight the importance of a master-controller sequence motif that controls both ɲSyn 29 
aggregation and function- a region that could be targeted to prevent aggregation in disease. 30 




The aggregation of ɲ-synuclein (ɲSyn), a neuronal protein with a primary locus at pre-synaptic nerve 33 
termini of the central nervous system1, is closely associated with Parkinsons disease (PD) and other 34 
synucleinopathies2,3. PD affects more than 1% of the world population over the age of 60 and 10 35 
million people worldwide4. The aetiology of PD and the processes by which ɲSyn self-assembles to 36 
and causes toxicity is not fully understood. For example, while monomeric ɲSyn is intrinsically 37 
disordered in vitro and in vivo5,6, it forms an array of oligomers7,8 and fibril structures9, only some of 38 
which are cytotoxic or infectious7. 39 
The primary sequence of ɲSyn comprises three regions (Figure 1A). The N-terminal region (residues 40 
1-60), is basic and contains 6 to 9 conserved imperfect repeats (KTKEGV) crucial for membrane 41 
binding10. The central NAC region (residues 61-95), has been shown to be necessary and sufficient 42 
for the aggregation of ɲSyn11,12. This region also forms the core of some, but not all, ɲSyn amyloid 43 
fibril structures13-15. Finally, the C-terminal region (residues 96-140) is highly flexible and enriched in 44 
acidic residues. Although ɲSyn is an intrinsically disordered protein (IDP), it has a smaller radius of 45 
gyration16-18 and collisional cross section19 than expected for a 140-residue random coil20. Its 46 
compaction is driven by transient long range electrostatic and hydrophobic interactions between the 47 
chemically distinct domains17,21. Given its distinct charge patterning (12 basic residues in the N-48 
terminal region and 15 acidic residues in the C-terminal region), the conformational properties of 49 
ɲSyn are dependent on the solution pH and ionic strength16-18,21, which in turn affect the aggregation 50 
rate of the NAC region22,23. 51 
The effects of sequence changes on the conformational properties and aggregation rates of IDPs 52 
have been widely studied24-28. Notably for ɲSyn, the seven known familial point mutations that lead 53 
to early onset PD are clustered in a region (residues 30-53) that flanks NAC (Figure 1A). Deletion of 54 
two of the imperfect repeats (residues 9-30), or truncation of the C-terminal region by 11 to 37 55 
residues, increase the rate of ɲSyn aggregation29-31, while insertion of two additional N-terminal 56 
imperfect repeats (by duplication of residues 9-30) inhibits aggregation30, highlighting the important, 57 
but complex, roles of these regions in modulating assembly. Other studies have suggested that the 58 
region preceding NAC (residues 47-56, known as PreNAC) is an important modulator of αSyn 59 
aggregation, as this region contains the familial mutations and is able to aggregate into amyloid-like 60 
fibrils in isolation32. This sequence also forms the inter-protofilament interface in some13,14,33, but not 61 
all13, αSyn amyloid fibril structures. However, the molecular mechanism(s) by which this region 62 
modulates assembly remain unclear.  63 
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Here, we used in silico methods to identify two sequence motifs named P1 (residues 36-42) and P2 64 
(residues 45-57) in the N-terminal region of αSyn that have limited solubility and significant 65 
aggregation propensity. We show that these regions are critical for aggregation in vitro and when 66 
expressed in vivo as a αSyn-YFP fusion in the bodywall muscle cells of C. elegans34. Paramagnetic 67 
relaxation enhancement (PRE) NMR experiments reveal pH- and salt-dependent interactions of 68 
these motifs with the NAC and C-terminal regions of the protein, the presence of which correlates 69 
with an increased aggregation rate. Finally, we show that P1 and P2 are important for αSyn-70 
mediated membrane fusion35,36, since their deletion prevents lipid tubule formation and alters the 71 
structure of the lipid-bound protein. Together, the results identify P1 as the master-controller of 72 
αSyn aggregation as this region governs the conformational properties and aggregation propensity 73 
of ɲSyn at neutral pH. This region also acts synergistically with P2 (PreNAC) to control assembly at 74 
low (lysosomal) pH. The results portray the tug-of-war between function and aggregation in this IDP, 75 
with the presence of the P1/P2 regions being essential for vesicle fusion, while simultaneously 76 
enhancing amyloid formation.   77 




Identification of the P1 and P2 motifs in the N-terminal region of ɲSyn  80 
To investigate the role of the flanking regions of ɲSyn in aggregation we analysed its sequence 81 
(Figure 1a) using Zyggregator (amyloid propensity37); Camsol (local solubility38) and ZipperDB (β-82 
zipper propensity39) (Figure 1b-e). This revealed three sequences in the N-terminal region predicted 83 
to have low solubility (similar to NAC): 2DVFMKGL7, 36GVLYVGS42 (named P1) and 84 
45KEGVVHGVATVAE57 (named P2). These regions also have high amyloid propensity as judged by 85 
Zyggregator, while ZipperDB identified P2, but not P1 or the N-terminal segment as aggregation-86 
prone. Since the role of the N-terminal region of αSyn (residues 1-30) has previously been studied by 87 
characterisation of deletion40 and extension30 variants, this region was not considered further here. 88 
The PreNAC region (residues 47-56) was identified by Eisenberg and colleagues32 and forms part of 89 
P2 (residues 45-57). This region also contains six of the seven known familial PD point mutations 90 
(Figure 1a). Previous studies have identified a potential role for the P1 and P2 regions in ɲSyn 91 
aggregation, with 47-56 forming amyloid-like aggregates in isolation32, while others have shown that 92 
inducing β-hairpin formation in the P1/P2 region (residues 37VLYVGSK43 and 48VVHGVAT54) stabilised 93 
by binding to a β-wrapin (an engineered  binding protein) prevents fibril formation41-43. Precisely 94 
how these sequences affect aggregation in the intact protein, however, remained unclear.  95 
The P1 and P2 regions control aggregation 96 
To investigate how P1 and P2 affect αSyn aggregation, these regions were deleted individually (ȴP1 97 
and ȴP2) or in tandem (ȴȴ) and the rate of aggregation monitored using thioflavin T (ThT) 98 
fluorescence and compared with those of WT αSyn (Figure 2a-d, Extended Data Figure 1a-h and 99 
Supplementary Table 1). The aggregates formed after 100 h were also imaged by negative stain 100 
transmission electron microscopy (TEM) (Extended Data Figure 1) and fibril yield determined by 101 
centrifugation (Supplementary Table 1). The results showed that decreasing the pH from 7.5 to 4.5 102 
(mimicking cytosolic and lysosomal pH, respectively) in 200 mM NaCl accelerates the rate of 103 
aggregation of WT αSyn, decreasing the lag-time ~6-fold and increasing the elongation rate ~10-fold 104 
(Figure 2a, Supplementary Table 1) consistent with previous results44,45. Aggregation of WT ɲSyn is 105 
also affected by ionic strength46, with assembly into amyloid occurring more rapidly at pH 4.5 at low 106 
(20mM added NaCl) compared with high (200 mM added NaCl) ionic strength, while aggregation is 107 
more rapid at pH 4.5 than pH 7.5 at both ionic strengths tested (Extended Data Figure 1a,b and 108 
Supplementary Table 1).   109 
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Remarkably, deleting the 7-residue P1 sequence abolished aggregation (over 100 h) at pH 7.5 at low 110 
and high ionic strength (Figure 2b, Extended Data Figure 1d, Supplementary Table 1). Deletion of P1 111 
has a smaller effect at pH 4.5, with little effect at low ionic strength and a ~2-fold increase in the lag 112 
time and a ~2-fold decrease in the elongation rate at high ionic strength (Figure 2b, Extended Data 113 
Figure 1c, Supplementary Table 1). By contrast, deletion of P2 results in only modest effects under 114 
all conditions studied (Figure 2c, Extended Data Figure 1e,f, Supplementary Table 1). Strikingly, the 115 
ΔΔ variant did not aggregate (over 100 h) at both pH values at high ionic strength, or at pH 7.5 at 116 
low ionic strength, and the lag time of assembly was increased ~15-fold at pH 4.5 in low ionic 117 
strength buffer (Figure 2d, Extended Data Figure 1g,h and Supplementary Table 1). This suggests a 118 
dominant role for P1 in controlling the aggregation rate of this 140-residue IDP and shows that the 119 
effects of P1 are synergistic with P2 at pH 4.5. ΔP1 and ΔΔ were also unable to elongate seeds 120 
formed at pH 7.5 from WT αSyn, whilst ΔP2 formed fibrils slowly (Extended Data Figure 2), 121 
suggestive of a structural incompatibility of these sequences with fibril seeds formed from the WT 122 
protein.  123 
The importance of P1 and P2 in promoting aggregation was also assessed by measuring the 124 
aggregation rate of disulfide cross-linked dimers of ɲSyn created by introducing Cys residues in P1 125 
(V40C), P2 (V52C) or at the C-terminus (A140C). In the presence of 2 mM DTT, each variant formed 126 
amyloid with kinetics similar to those of WT ɲSyn (Figure 3a-c, Supplementary Table 1). Dimerisation 127 
(confirmed by SEC-MALS (see Methods)) prevented aggregation (for at least 140 h) for V40C (Figure 128 
3a). However, such an effect was not observed for V52C or A140C (Figure 3b,c, Supplementary Table 129 
1), supporting the finding that P1 is important for aggregation. The positional sensitivity of the 130 
dimerisation site was not observed previously when αSyn was cross-linked by dityrosine formation 131 
at Y39 and Y125, Y133 or Y13647 suggesting a strict steric/positional sensitivity of inhibition. This 132 
could act at the stage of dimer formation, or by the imposed dimerisation altering the structure of 133 
seeds/oligomers formed later during assembly. 134 
The presence of up to nine imperfect repetitive KTKEGV sequences in the N-terminal region of αSyn 135 
raised the possibility that the effects of deleting P1 and/or P2 may result from changes in the spatial 136 
organisation of the repeats (Figure 1b). To assess this possibility, a variant was constructed in which 137 
a seven-residue sequence in a different location in the N-terminal region was deleted (residues 14-138 
20, denoted ΔC1) (Figure 1b). ΔC1 was designed to mimic the general features of P1 as closely as 139 
possible i.e. the sequence deleted is of the same length and similar positioning between imperfect 140 
repeats as P1. In contrast to the marked effects of deleting P1, ΔC1 had no significant effect at pH 141 
7.5 or pH 4.5 at high ionic strength, and even accelerated aggregation (decreasing the lag-time ~10-142 
7 
 
fold) at pH 4.5 at low ionic strength (Extended Data Figure 3a-d, Supplementary Table 1). Fibrils were 143 
also observed after 140 hours in all conditions as judged by negative stain EM and quantification of 144 
soluble protein remaining (Extended Data Figure 3g, Supplementary Table 1). A second control 145 
variant, named P1P2-GS, was also created in which the 7 residues in P1 and 13 residues in P2 were 146 
replaced with alternating Gly-Ser sequences, 7 and 13 residues in length, respectively, preserving the 147 
spacing of the imperfect repeats (Extended Data Figure 3a). At pH 7.5 P1P2-GS did not aggregate at 148 
low or high ionic strength, similar to the behaviour of ȴȴ (Extended Data Figure 3g,i, Supplementary 149 
Table 1). At pH 4.5, aggregation did occur (Extended Data Figure 3f,i, but was significantly retarded 150 
compared with WT ɲSyn  (Supplementary Table 1). These data show that the effect of P1 and P2 on 151 
aggregation is mainly sequence-specific and does not result from alterations in the length of the N-152 
terminal region or the spacing of the imperfect repeats. 153 
P1 and P2 make multiple intra-molecular contacts that promote amyloid formation 154 
To determine whether P1 and P2 affect the conformational properties of αSyn monomers that alter 155 
their ability to assemble into amyloid, WT ɲSyn and ȴȴ were examined using Paramagnetic 156 
Relaxation Enhancement NMR (PRE NMR). This approach allows rare (0.5  5 % population) and 157 
transient interactions to be investigated. Previous studies used NMR PREs to investigate the 158 
conformational properties of WT ɲSyn at pH 2.5, 3.0, 6.0, 7.4 and 7.5 using protein concentrations 159 
from 100 ʅM to 650 ʅM at 15 °C17,21,44,48-50. The familial PD mutations (A30P, A53T)51 and β- and γ-160 
Syn52 have also been investigated using this approach. To determine how deletion of P1 and P2 161 
affects the conformational properties of αSyn monomers, 15N WT ɲSyn containing a single Cys 162 
introduced at positions 18 (ɲSyn A18C), 90 (ɲSyn A90C), or 140 (ɲSyn A140C) were expressed, 163 
purified and their 1H-15N HSQC spectra assigned at pH 4.5 (Methods). Each protein was then 164 
covalently labelled with the paramagnetic spin label S-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-165 
pyrrol-3-yl)methyl methanesulfonothioate (MTSL) and NMR PRE experiments performed to detect 166 
transient intramolecular interactions. Control experiments confirmed that inter-molecular 167 
interactions are not observed at the protein concentration used (see Methods). Under conditions 168 
that promote rapid aggregation of WT ɲSyn (pH 4.5, 20 mM NaCl (low salt), Figure 4a) long range 169 
intramolecular interactions between specific regions are observed for all three PRE probes (Figure 170 
4b,d,f, Extended Data Figure 4). Specific intramolecular interactions between the N- and C-terminal 171 
regions of the protein were observed, as exemplified by significant PRE effects when MTSL was 172 
placed at residue 18 (Figure 4b), with a smaller reciprocal PRE effect from MTSL at residue 140 with 173 
the N-terminal region (Figure 4f)), consistent with previous results at other pH values17,23,44. 174 
Significant contacts are also observed between NAC and the C-terminal region, consistent with 175 
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previous analyses at pH 2.5 and 3.021,44. Importantly, and by contrast with previous results23, 176 
significant PREs are observed between P1 (and some residues in P2) and residues near the N-177 
terminus (using ɲSyn A18, Figure 4b), as well as to NAC (using ɲSyn A90C, Figure 4d) and to C-178 
terminal regions (using αSyn A140C, Figure 4f). Previous meta-analysis of 11 PRE NMR studies also 179 
showed evidence of the P1 and P2 regions as an interaction hub53. Importantly, under conditions in 180 
which aggregation is slowed (pH 4.5, 200 mM NaCl (high salt)) (Figure 4a), these intramolecular 181 
interactions to P1/P2 (most markedly those involving PREs from residues 90 and 140) are decreased 182 
in magnitude (compare Figure 4b,d,f with Figure 4c,e,g), consistent with electrostatic interactions, 183 
possibly involving K45, E46, H49 or E57 in P2, or residues that juxtapose P1 (K32, K34, E35, K43) 184 
and/or P2 (E61), being involved. The observation that weaker long range intra-molecular 185 
interactions with P1/P2 results in slower aggregation kinetics suggests that these interactions are 186 
important in defining the aggregation rate.  187 
To determine how removing P1 and P2 affects the conformational properties of monomeric ɲSyn, 188 
the PRE experiments were repeated under identical conditions (pH 4.5 at low and high ionic 189 
strength) using ȴȴ ɲSyn. These conditions result in slow (low salt) or no (high salt) fibril formation, 190 
respectively (Figure 5a). The resulting PRE profiles (Figure 5b-g) show that the long range contacts 191 
between the N- and C-terminal regions and the NAC and C-terminal region are mostly maintained in 192 
ȴȴ, while contacts to P1/P2 were removed. Interestingly, while contacts between the N-terminal 193 
region (residue 18) and NAC/C-terminal region and NAC (residue 90) and the N-/C-terminal regions 194 
are similar in WT and ΔΔ ɲSyn, those between the C-terminal region (residue 140) and the N-195 
terminal region are smaller in ΔΔ, indicative of a complex interplay of interactions that depends 196 
intimately on the sequence and solution conditions. A further control experiment in which 197 
intramolecular PREs were measured for P1P2-GS with MTSL at residue 90 showed a similar response, 198 
with the long range intra-molecular PREs remaining in this construct and hints that the PRE effect to 199 
the P1 and P2 regions observed for WT ɲSyn, is significantly reduced in P1P2-GS (Extended Data 200 
Figure 5).Thus, removal of P1/P2 does not prevent compaction of the ɲSyn sequence, yet a 201 
significant reduction in aggregation is observed, demonstrating the crucial importance of the P1/P2 202 
sequences in determining the aggregation of ɲSyn.  203 
The roles of P1 and P2 in initiating intermolecular interactions 204 
At high protein concentrations (500 ʅM), ɲSyn forms transient inter-molecular interactions, in which 205 
residues 38-45 (corresponding closely to the P1 region (36-42)), make weak inter-chain interactions 206 
with residues 124-140, at least at pH 6.0 at low ionic strength (10 mM MES, 0 M NaCl)54. To 207 
determine whether removal of P1 and P2 disrupts these inter-molecular interactions, 250 µM 14N 208 
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ɲSyn was labelled with MTSL at residue 40 (V40C) or 129 (S129C) and incubated with 250 µM 15N WT 209 
ɲSyn at pH 4.5 at low and high ionic strength. Intermolecular PREs (via R2 relaxation experiments) 210 
were then measured to identify inter-chain contacts (Extended Data Figure 6a,b). The results 211 
showed that residue 40 (in the P1 region) makes intermolecular contacts primarily with residues in 212 
the negatively charged C-terminal region of WT αSyn (Extended Data Figure 6b), in agreement with 213 
published results54. At high ionic strength (retarded aggregation), this effect is decreased, consistent 214 
with these inter-molecular interactions being important in the early stages of aggregation (Extended 215 
Data Figure 6b). Finally, intermolecular PREs were determined with MTSL at residue 129 (Extended 216 
Data Figure 6c). These experiments showed a significant PRE from residue 129 to the P1 and P2 217 
regions, as well as to the N-terminal ~20 residues in WT αSyn. Importantly, the latter interactions 218 
are maintained in ΔΔ, whilst interactions with P1/P2 are no longer possible (Extended Data Figure 219 
6c), showing that the inter-molecular contacts between the N- and C-termini are independent of the 220 
presence of P1/P2. Together, the results reinforce the importance of the P1/P2 regions in driving 221 
aggregation, not just because of their local insolubility and high aggregation-propensity, but also 222 
because they determine the conformational properties of the monomeric IDP and formation of 223 
transient intermolecular interactions with the C-terminal region, that define its ability to aggregate 224 
into amyloid.  225 
P1 and P2 are drivers of aggregation in vivo 226 
The effect of deleting P1 and P2 on αSyn aggregation in vivo was assessed by expressing WT αSyn, 227 
ΔP1 or ΔΔ  fused C-terminally to YFP in C. elegans muscle cells34. Figure 6a shows that WT αSyn::YFP 228 
forms inclusions that are visible as foci in L4 larvae (Day 0). Foci increase in number as the animals 229 
age, and the proteostasis network declines55,56, reaching a plateau from Day 3 to Day 13 of 230 
adulthood, as reported previously34. In marked contrast, animals expressing ΔP1::YFP or ΔΔ::YFP 231 
formed few, if any, visible aggregates throughout ageing (Figure 6a,b), even though the expression 232 
levels of these proteins is higher than WT αSyn (Figure 6c). Notably, by contrast with WT αSyn::YFP, 233 
the total number of ΔP1::YFP or ΔΔ::YFP foci did not increase during ageing, with few aggregates 234 
observed even at Day 13 (Figure 6b). The percentage of immobile WT αSyn::YFP aggregates 235 
increased ~4-fold from Day 7 to Day 13 of adulthood as measured by FRAP (Figure 6b). By 236 
comparison, ΔP1 and ΔΔ  αSyn::YFP formed only few aggregates (1 to 2 foci) that were immobile 237 
(Figure 6b). Even in aged worms motility remained similar to healthy N2 wild-type animals between 238 
Days 0-3 (Figure 6d), with slightly reduced (2-fold) thrashing rates observed in ΔΔ::YFP and ΔP1::YFP 239 
at Day 13 of adulthood (Figure 6d). In contrast, C. elegans expressing WT αSyn::YFP showed an age-240 
dependent decline of motility between Days 3 and 13 compared with N2 worms (Figure 6d). Thus, 241 
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deletion of P1 or both P1/P2 prevents both age-dependent aggregation of ɲSyn in vivo and 242 
suppresses aggregation-induced proteotoxicity.  243 
The importance of P1/P2 in membrane remodelling 244 
As P1 and P2 are located in the membrane-binding N-terminal region of ɲSyn, we explored whether 245 
P1/P2 also play a role in the function of ɲSyn in remodelling membrane vesicles35,57,58. ɲSyn forms α-246 
helical structure in its N-terminal region (residues 1-97) upon membrane binding59,60 which 247 
subsequently enhances aggregation of the protein into amyloid fibrils61. To determine whether ȴȴ is 248 
also able to adopt α-helical structure upon lipid binding, and whether this induces fibril formation, 249 
the protein was incubated with liposomes prepared from 1,2-dimyristoyl-sn-glycero-3-phospho-L-250 
serine (DMPS), one of the major lipids in synaptic vesicles. The secondary structure of the protein 251 
was then monitored using far UV CD. The resulting data (Figure 7a,b and Extended Data Figure 7a) 252 
showed that ȴȴ is able to bind to these vesicles, but adopts only 30% helical structure when 253 
membrane bound, whilst 64 % helicity would be expected assuming similar helix formation to WT 254 
αSyn. Lipid titration experiments revealed that the affinity of ȴȴ for lipid is ~10-fold weaker than WT 255 
αSyn (KD = 2.01 ± 0.63 µM and 0.22 ± 0.13 µM for ȴȴ and WT ɲSyn, respectively) (Figure 7a,b, 256 
Extended Data Figure 7b). The stoichiometry value, L, indicative of the total number of DMPS 257 
molecules in the bilayer involved in binding one ɲSyn molecule, is similar for both proteins (49 and 258 
33, respectively) (Figure 7a,b, Extended Data Figure 7b). P1P2-GS responds to DMPS liposomes 259 
similarly to ΔΔ (Figure 7c, Extended Data Figure 7b,c). Thus, the effect of P1/P2 is sequence specific 260 
and does not result from changing the spacing of the imperfect repeats.  261 
DMPS liposomes have also been shown to accelerate ɲSyn aggregation by promoting heterogeneous 262 
primary nucleation61. To assess whether ȴȴ ɲSyn is able to nucleate amyloid formation when bound 263 
to these 160 nm diameter liposomes (Extended Data Figure 7d), the aggregation kinetics of WT 264 
ɲSyn, ȴȴ and P1P2-GS were monitored at different [DMPS]:[ɲSyn] molar ratios (Figure 7d-f). 265 
Consistent with previous results, WT ɲSyn does not form amyloid in the absence of liposomes under 266 
the conditions employed (20 mM sodium phosphate, pH 6.5)61, while an excess of lipid (60:1 [M:M]) 267 
also prevents aggregation by depleting the concentration of lipid-free monomer available for 268 
elongation61. At an 8:1 [DMPS]:[ɲSyn] ratio, however, WT ɲSyn aggregates rapidly (Figure 7d), as 269 
reported previously61. While ȴȴ is able to nucleate amyloid formation at a ratio of 8:1 [M:M] 270 
[DMPS]:[ɲSyn], the rate of aggregation is slowed significantly (lag times = 4.9 ± 0.3 h and 93.0 ± 2.6 h 271 
for WT and ȴȴ, respectively) (Figure 7e, Supplementary Table 1), presumably because less helical 272 
structure is formed in ȴȴ in the lipid-bound state. Consistent with this P1P2-GS is able to aggregate, 273 
but very slowly, when lipid bound (Figure 7c,f and Extended Data Figure 7b). Negative stain TEM of 274 
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sample at the endpoints of these incubations at 60:1 [DMPS]:[ɲSyn] [M:M] are shown in (Figures 7g-275 
i). Remarkably, while WT αSyn causes the coalescence of liposomes into long lipid tubes, as reported 276 
previously35, this is not observed upon incubation with ȴȴ or P1P2-GS. Instead, incubation with 277 
these proteins results in the formation of small, prefibrillar-like aggregates (Figure 7h,i (inset)) which 278 
associate with the liposome surfaces and appear to cause liposome fission, releasing smaller 279 
spherical liposomes (Figure 7h,i). Thus, in addition to controlling the aggregation of ɲSyn in vitro and 280 
in vivo, P1/P2 affect the function of ɲSyn in re-modelling lipid vesicles. 281 
Finally, membrane binding of WT, ΔΔ and P1P2-GS were measured in residue-specific detail by 282 
acquiring 15N-1H HSQC NMR spectra of the proteins in the presence or absence of saturating 283 
amounts (60:1 {M:M] [DMPS]:[ɲSyn]) of liposomes (Figure 8a-c). Due to the slow tumbling rates of 284 
liposomes, resonances of residues that bind strongly are reduced in intensity, whilst those of lipid 285 
free/weakly bound residues have higher intensity in the liposome-bound state62. Strikingly, these 286 
data showed significant differences in the residues involved in lipid binding, with all but the C-287 
terminal ~20 residues binding strongly to lipid in ΔΔ, whilst a much smaller interface is formed for 288 
WT αSyn. P1P2-GS exhibited intermediate behaviour, suggesting that both the sequence and the 289 
relative position of P1 and P2 play a role in lipid binding (Figure 8d). Thus, the P1/P2-regions control 290 
the lipid-binding properties of distal regions of the αSyn sequence, structure in the lipid-bound state 291 
and perturb membrane remodelling, without preventing binding to DMPS liposomes.  292 




The P1 sequence is a master-controller of αSyn aggregation 295 
We have identified a sequence in the N-terminal region of αSyn (residues 36-42 (P1)) that plays a 296 
key role in determining the ability of the protein to form amyloid fibrils in vitro and in vivo. 297 
Remarkably, we show that the seven residue P1 segment is specifically required for aggregation, 298 
with its deletion preventing aggregation in vitro at neutral pH and in bodywall muscle cells of C. 299 
elegans, despite the protein retaining the crucial NAC region12. By performing aggregation assays 300 
and NMR PRE experiments under conditions which either favour (pH 4.5 (lysosomal conditions), low 301 
ionic strength) or deter (pH 7.5 (cytosolic), high ionic strength) (Supplementary 302 
 Table 1) amyloid growth, we have been able to correlate changes in monomer conformation (e.g. 303 
changes in the intra-molecular long-range interactions for P1/P2 measured by NMR-PRE at pH 4.5) 304 
induced by sequence changes in the P1/P2 region with aggregation propensity. Based on these 305 
observations we define the P1 region as a master-controller of αSyn aggregation, in that this region 306 
controls αSyn self-assembly, synergistically with the P2 (Pre-NAC) region32 under some conditions 307 
(specifically at low pH values that mimic the lysosomal environment, relevant for ɲSyn in vivo63). 308 
These regions exert their control by fine-tuning intra- and inter-molecular contacts both locally 309 
within the N-terminal region, and with the distal NAC and C-terminal regions, yielding a 310 
conformational ensemble that is either aggregation-prone (retaining P1 or P1/P2) or protected from 311 
aggregation (P1 or P1/P2 deleted or substituted with Gly-Ser), presumably via 312 
exposure/sequestration of the crucial12,22,23 NAC region. The precise molecular mechanism by which 313 
this is accomplished, including the relative importance of each residue in P1 in defining the proteins 314 
behaviour, remain to be elucidated. Deletion of P1/P2 could also affect the structure and 315 
aggregation-competence of oligomers formed later during aggregation. Whatever the precise 316 
mechanism of action, the sensitivity of aggregation to pH and ionic strength suggests that P1/P2 317 
control ɲSyn aggregation by a delicate balance of hydrophobicity and charge, such that aggregation 318 
becomes highly sensitive to the solution conditions. This may rationalise why P1/P2 interactions 319 
eluded detection in previous studies at pH values below21,44,48 or above17,44,48-50 pH 4.5. Thus, while 320 
NAC is necessary and sufficient for αSyn aggregation12, the ability to prevent aggregation at pH 7.5 321 
by removal or substitution of a single, specific, 7-residue sequence provides a striking demonstration 322 
of the crucial effect of flanking regions in amyloid formation.  323 
The importance of flanking region(s) has been demonstrated for other aggregation-prone proteins, 324 
including the P17 region in exon 1 of huntingtin25,26,28, the N-terminal region (residue 11-16) of 325 
13 
 
amyloid ɴ (Aɴ40)64, residues 306-311 in tau65, the aggregation prone motifs 1422, 5358, and 6972 326 
in the N-terminal region of Apo-I24 and the N-terminal six amino acids of ɴ2-microglobulin66. At 327 
longer timescales, or under more favourable conditions for aggregation (e.g. at pH 4.5 and low ionic 328 
strength (Extended Data Figure 1g) or at pH 6.5 in the presence of DMPS liposomes (Figure 7e)), ȴȴ 329 
is able to form amyloid, highlighting the crucial role of the transient intra- and inter-molecular 330 
interactions made by the N-terminal region of αSyn in imposing kinetic control on the 331 
thermodynamically favourable process of amyloid formation.  332 
Our discovery that P1 and P2 are also required for the function of αSyn in vesicle remodelling adds 333 
to the growing evidence that the N-terminal region of αSyn is important for both its physiological 334 
function and its disease aetiology57,67. Notably, P2 encompasses six of the seven early onset familial 335 
PD mutations68 (Figure 1b). This region also forms the protofilament interface in some13,14,33, but not 336 
all13, structures of αSyn fibrils formed in vitro, and this region can form amyloid in isolation32. Hoyer 337 
and colleagues also showed that the aggregation of αSyn can be inhibited in vitro and in vivo by the 338 
binding of a ɴ-wrapin41,43 to residues 37-54, which encompasses both P1 and P2, with the NMR 339 
structure of the complex revealing ɴ-hairpin formation involving residues 37VLYVGSK43 and 340 
48VVHGVAT54 of αSyn41. Engineering an intramolecular disulphide bond between residues 41 and 48 341 
has also been shown to inhibit αSyn aggregation in the absence of β-hairpin formation42, 342 
presumably because this perturbs the structure around P1 and P2 that we show here to be vital for 343 
fibril formation. Mutation of Y39 to Ala also prevents aggregation and Y39 has been shown to be 344 
responsible (together with F94) for binding small molecules able to retard aggregation62. Finally, a 345 
cyclised peptide of residue 36-55 has been shown to adopt a ɴ-hairpin structure that self-assembles 346 
into cytotoxic oligomers, the authors suggesting that this region, rather than NAC, nucleates 347 
oligomer formation11. Together, the data presented here highlight the vital importance of P1 and P2 348 
in controlling αSyn aggregation, demonstrating that aggregation is not initiated by the NAC region 349 
alone. Using a C. elegans model expressing αSyn in the bodywall muscles, deletion of P1 or both P1 350 
and P2 suppressed age-dependent αSyn inclusion body formation as well as the associated toxicity, 351 
resulting in animals with improved health-span, even at advanced age. Displacing the interactions 352 
made by P1 and/or P2 may thus pave the way to routes to control αSyn aggregation using small 353 
molecules or other reagents that target these sites. 354 
Frustration between aggregation and function  355 
Given that deletion of P1 and P2 neutralises the deleterious effects of NAC on αSyn aggregation, 356 
why is the sequence of these regions retained by evolution? While the physiological function(s) of 357 
αSyn remain unclear, stabilisation, sequestration, and fusion of pre-synaptic vesicles are thought to 358 
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be involved in its repertoire of functions36,57,69. Distinct membrane binding sites within the N-359 
terminal region involving residues 1-25 and 65-97 have been proposed to play a critical role in 360 
tethering vesicles prior to membrane fusion35,36. Here we show that deleting part of the passive 361 
linker region between these two sites (residues 36-57 in P1/P2) prevents the function of αSyn in 362 
membrane remodelling, generating liposome morphologies that are distinct from the large fused 363 
tubular structures formed by the WT protein (Figure 7g-i). Together with their effects on 364 
aggregation, the results demonstrate the frustration between function and aggregation in this IDP, 365 
with the presence of the P1/P2 region being required for function, whilst simultaneously generating 366 
a sequence that enhances amyloid assembly. Such a delicate balance rationalises why single point 367 
mutations such as A53T, E46K and others68, enhance Parkinsons disease onset by simultaneously 368 
causing loss-of-function and gain-of-toxic function activities. For an IDP such as αSyn the aggregation 369 
propensity of such aggregation-prone, yet functionally important regions, cannot be protected by 370 
the framework of a folded tertiary structure, making such sequences especially prone to be the 371 
causative agents of disease. Indeed 17 of the 48 currently known human amyloidogenic proteins are 372 
IDPs or contain intrinsically disordered regions3. Such sequences enable dangerous liaisons since 373 
their intrinsic amyloid potential is exposed, unabridged by the protection of a native structure. 374 
Nonetheless, the presence of such newly discovered and characterised master-controllers of 375 
aggregation within the ɲSyn sequence offers exciting potentials to control amyloid formation by 376 
binding small molecules, chaperones, biologics or other agents to these regions. Given the fine 377 
balance of weak intra- and inter-molecular interactions that control the early stages of aggregation 378 
into amyloid, minor alterations in the shape of the interaction energy landscape could disable 379 
aggregation without significantly perturbing function. Further experiments will be needed to identify 380 
whether other IDPs contain master-controllers of aggregation, to identify the role of each of the 381 
seven amino acids in P1 in encoding the ability to control αSyn aggregation and function and to 382 
clarify the molecular mechanism of fibril growth inhibition by P1 in more detail.  383 
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Figure Legends 589 
Figure 1. Aggregation and solubility profiles of ɲSyn. a) The sequence of human ɲSyn. The N-590 
terminal region (1-60), NAC region (61-95) and C-terminal region (96-140) are coloured in blue, pink, 591 
and red, respectively. The C1 and P1/P2 regions shown in (b) are coloured pale grey and dark grey 592 
respectively. The imperfect KTKEGV repeats are underlined in blue. b) Regions of αSyn highlighting 593 
the imperfect KTKEGV repeats in the N-terminal region (light blue), the positions of the seven 594 
familial PD mutants, and the P1, P2 and C1 control sequence highlighted as in (a). c), d) and e) 595 
Zyggregator37, Camsol38 and ZipperDB39 profiles for the ɲSyn sequence, respectively. Red bars 596 
indicate aggregation-prone/low solubility regions. Yellow bars indicate residues with a higher than 597 
average aggregation propensity/low solubility, but which do not meet the threshold. Red dashed 598 
lines indicate the low solubility/high aggregation propensity threshold, while green dashed lines 599 
show threshold values for high solubility/low aggregation propensity. For Zipper DB, the yellow 600 
dashed line shows the threshold value of residues with a high probability of β-zipper formation39. 601 
Data for graphs in c-e are available as Source Data. 602 
 603 
Figure 2. The kinetics of aggregation of WT ɲSyn and P1/P2 deletion variants. a-d The 604 
aggregation kinetics of 100 µM WT αSyn (a); ȴP1 (b); ȴP2 (c) or ȴȴ variants (d). Dark and light 605 
colours denote incubations carried out at pH 7.5 (20 mM Tris HCl, 200 mM NaCl, pH 7.5) or pH 4.5 606 
(20 mM sodium acetate, 200 mM NaCl, pH 4.5), respectively. All experiments were carried out at 37 607 
°C with agitation at 600 rpm and measured in at least triplicate. Lag times and elongation rates were 608 
determined for every single curve using OriginPro (see Methods), means and s.d. are listed in 609 
Supplementary Table 1. The fibril yield under each condition, determined by SDS PAGE subsequent 610 
to centrifugation (see Methods), is shown in Supplementary Table 1. Data for all graphs are available 611 
as Source Data. 612 
 613 
Figure 3. ThT fluorescence assays of disulfide locked ɲSyn dimers. a-c Aggregation kinetics 614 
and negative stain TEM images of endpoint (140 h) aggregates of 100 ʅM V40C (a), V52C (b)  or 615 
A140C (c) monomers or dimers. Incubations of monomeric or disulfide locked dimers of ɲSyn are 616 
shown in light and dark red, respectively. Aggregation kinetics of WT ɲSyn are shown in blue. The 617 
same data for the WT αSyn are shown overlaid for all three variants. All experiments were measured 618 
in at least triplicate. TEMs with light border show end point images of reduced samples and dark 619 
borders show end point images of disulfide bonded dimers. Each image was collected from a 620 
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representative sample for each condition., All assays were carried out in 20 mM sodium acetate 621 
buffer, containing 200 mM NaCl, pH 4.5 (including 2 mM DTT for reduced samples), 37 °C with 622 
agitation at 600 rpm. Data for all ThT graphs are available as Source Data. 623 
 624 
Figure 4. Intramolecular PRE experiments for WT ɲSyn. a) Aggregation kinetics (note the short 625 
timescale depicted) of WT αSyn (100 µM in 20 mM sodium acetate, pH 4.5, at low (20 mM added 626 
NaCl) or high (200 mM added NaCl) ionic strength at 37 °C). b-g Intramolecular PRE intensity ratios of 627 
amide protons (paramagnetic/diamagnetic) for WT ɲSyn variants with MTSL spin labels at A18C 628 
(b,c), A90C (d,e) or A140C (f,g) at low (b,d,f) or high (c,e,g) ionic strengths, 15 °C , as indicated. Blue, 629 
pink and red bars show intensity ratios for the N-terminal, NAC and C-terminal regions, respectively. 630 
Dark blue bars highlighted in grey point out the position of the P1/P2 region.  Schematics are shown 631 
above each plot with a consistent colour scheme. The location of spin labels are denoted by a yellow 632 
circle. Grey panels highlight the location of the P1/P2 regions. Data for all graphs are available as 633 
Source Data. 634 
 635 
Figure 5. Intramolecular PRE experiments for  ɲSyn. a) Aggregation kinetics (note different 636 
timescale compared with Extended Data Figure 1) of ΔΔ and WT αSyn (100 µM in 20 mM sodium 637 
acetate, pH 4.5, 37 °C at low (20 mM added NaCl) or high (200 mM added NaCl) ionic strength). b-g)  638 
Intramolecular PRE intensity ratios of amide protons (paramagnetic/diamagnetic) for variants with 639 
MTSL spin labels at A18C (b,c), A90C (d,e) or A140C (f,g) at low (b,d,f) or high (c,e,g) ionic strengths, 640 
at 15 °C, as indicated. Data for all graphs are available as Source Data. 641 
 642 
Figure 6. Deletion of P1 or P1/P2 in C. elegans expressing ɲSyn::YFP suppresses 643 
aggregation and proteotoxicity. a) Confocal microscopy images showing the head region of 644 
transgenic C. elegans expressing WT αSyn, ȴȴ or ȴP1 tagged C-terminally to YFP in the bodywall 645 
muscle during ageing (Day 0 to Day 13 of adulthood). Scale bar, 10 µm. b) Number of mobile and 646 
immobile inclusions larger than ~2 µm2 per animal between the tip of the nose and pharyngeal bulb 647 
during ageing determined using FRAP. Data shown are the mean and s.e.m. for three independent 648 
experiments (biological replicates); in each experiment, 10 worms (n = 10) were assessed for each 649 
time point. (n=10 worms). Blue stars indicate significance between the number of mobile aggregates 650 
of animals expressing WT ɲSyn or the variants ΔP1 or ΔΔ. Red stars indicate significance between 651 
the number of immobile aggregates exhibited in animals expressing WT ɲSyn compared with 652 
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mutant animals. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001. A one-sided Students t test was 653 
used in all cases. c) Western blot analysis of protein extracts isolated from N2, WT ɲSyn::YFP, 654 
ȴP1::YFP and ȴȴ::YFP animals using an anti-ɲSyn antibody (Methods). Tubulin was used as a loading 655 
control. The loading control (anti-tubulin) was run on a different gel/membranes loaded with the 656 
same protein sample and treated and analysed in the same manner. The images were cropped 657 
showing all relevant bands. (d) Number of body bends per second (BBPS) of N2, WT 658 
ɲSyn::YFP, ȴP1::YFP and ȴȴ::YFP animals from Day 0 (L4 stage) through to Day 13 of adulthood. Data 659 
shown are mean and s.e.m. for three independent experiment; in each experiment, 10 worms were 660 
assessed for each time point.  n=10 for each experiment and error bars represent SEM of three 661 
biological replicates. n.s. = not significant; **P<0.01; *P<0.05, a one-sided test was used. Data for 662 
graphs in b-d are available as Source Data. 663 
 664 
Figure 7. Lipid-induced aggregation kinetics of WT αSyn and its variants. a-c Far-UV CD 665 
spectra of 25 ʅM WT ɲSyn (a), ΔΔ (b) or P1P2-GS (c) incubated with increasing ratios of 666 
[DMPS]:[protein] . KD and L values were calculated from the change in MRE at ʄ222nm fitted to a single 667 
step binding model61 (Extended Data Figure 7b). Aggregation kinetics of 50 ʅM αSyn WT (d), ΔΔ (e) 668 
or P1P2-GS (f) incubated with 0:1, 8:1 or 60:1 [DMPS]:[protein] (20 mM sodium phosphate, pH 6.5; 669 
30 °C, no shaking). g-j TEM images of representative samples of WT ɲSyn (g), ȴȴ (h) or P1P2-GS (i) at 670 
the endpoint of the incubations (150 h) in the presence of 60:1 [DMPS]:[protein]. Data for graphs in 671 
a-f are available as Source Data. 672 
 673 
Figure 8. NMR experiments detailing the molecular basis of liposome binding of WT ɲSyn 674 
 and P1P2-GS. 1H-15N HSQC NMR spectra of a) WT ɲSyn, b) ΔΔ and c) P1P2-GS in the presence 675 
(green) or absence (orange) of a 60:1 ratio of [DMPS]:[protein]. d) Intensity ratios (presence/absence 676 
of liposomes) of cross-peaks for WT ɲSyn (blue), ΔΔ (red) and P1P2-GS (orange) are shown by 677 
illustrating the median value over a rolling window of five residues determined using OriginPro. The 678 
position of P1 and P2 is highlighted with grey bars. Note that residues 36-42 and 45-57 are deleted in 679 
ΔΔ and these residues (replaced with (SG)3S (P1) and (GS)6G (P2)) could not be assigned for P1P2-GS. 680 
Data for graph in d are available as Source Data. 681 




Mutagenesis, expression and purification 684 
ɲSyn containing single Cys variants, the P1P2-GS control (P1 (7 aa) replaced with (SG)3S and P2 (13 685 
aa) with (GS)6G) and/or deletions of C1, P1 and/or the P2 regions were engineered into the gene 686 
sequence for WT ɲSyn via Q5 site directed mutagenesis (NEB). 14N, 15N and 13C/15N labelled ɲSyn 687 
variants were expressed recombinantly in Escherichia coli BL21 (DE3) cells and the protein purified 688 
as described previously70. In the case of 15N and/or 13C labelled protein, expression was performed in 689 
HCDM1 minimal medium with 15N enriched NH4Cl and 
13C enriched glucose. Note that by contrast 690 
with Masuda et al.71 there was no evidence of mis-incorporation of Cys for Try at residue 136, as the 691 
correct molecular masses of all proteins were confirmed by mass spectrometry (WT: 14 459 ± 0.27 692 
Da; ȴP1: 13 784 ± 0.50 Da; ȴP2: 13 182 ± 0.96 Da; ȴȴ: 12506 ± 0.03 Da; ȴC1: 13 861 ± 0.56 Da; P1P2-693 
GS: 13947.4 ± 0.06 Da) (spectra are available at https://doi.org/10.5518/707). Additionally, the NMR 694 
spectrum of all proteins was fully assigned with residue 136 being confirmed as Tyr. Proteins were 695 
lyophilised and stored at -20°C. Proteins were resolubilised in buffer immediately before 696 
experiments were carried out. There was no evidence for covalent dimers forming during storage 697 
(samples were analysed before and after storage by ESI-MS). Different buffer conditions were used 698 
to analyse the behaviour of the proteins at pH 7.5 (20mM Tris HCl) or pH 4.5 (20 mM sodium 699 
acetate), with high (200 mM NaCl) or low (20 mM NaCl) salt concentrations. The isoelectric points of 700 
the protein variants are: WT: 4.67; ȴP1: 4.67; ȴP2: 4.60; ȴȴ: 4.60; ȴC1: 4.72; P1P2-GS: 4.60 701 
(calculated using ProtParam tool from ExPASy). 702 
In silico methods to determine aggregation propensity 703 
The aggregation propensity was analysed by using the online tools Camsol38, Zyggregator37 and 704 
ZipperDB39 at pH 7.0.   705 
Aggregation assays monitored by ThT fluorescence 706 
100 ʅL samples of 100 ʅM ɲSyn variants in the required buffers were incubated with 20 ʅM ThT in 707 
sealed 96-well flat bottom assay plates (Corning, non-binding surface) in a FLUOstar Omega plate 708 
reader (BMG Labtech) at 37 oC with continuous orbital agitation at 600 rpm. The fluorescence of ThT 709 
was excited at 444 nm and fluorescence emission was monitored at 480 nm. The elongation rate was 710 
determined by fitting a gradient to the linear part of the ThT-curve, the lag time was taken as the 711 
intercept of the line to the baseline fluorescence signal, using OriginPro software (OriginPro 2018b 712 
64Bit). This analysis was performed with a minimum of three replicate experiments. The standard 713 
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deviations were calculated for repeated measurements (Supplementary Table 1). Fibril yields were 714 
determined via centrifugation (30 min 13,000 rpm (Microfuge SN 100/90) and analysis of remaining 715 
soluble material compared to the starting material using SDS PAGE. For this, SDS-PAGE gels were 716 
imaged on the Alliance Q9 Imager (Uvitec) and band intensities were determined using ImageJ 717 
1.52a. Repeat experiments and loading controls indicating an error of ~10% in quantifying band 718 
intensity using this approach. Experiments monitoring lipid-induced aggregation were performed as 719 
above, except that aggregation was followed under quiescent conditions, 30 oC with a protein 720 
concentration of 50 ʅM. To prepare seeds of WT ɲSyn, 500 ʅL of 600 ʅM ɲSyn in Tris HCl pH 7.5, 20 721 
mM NaCl was stirred with a magnet stirrer at 1200 rpm at 45 °C for 48 h. Fibrils were then sonicated 722 
twice for 30 sec with a break of 30 sec at 40 % maximum power using a Cole-Parmer-Ultraprocessor-723 
Sonicator. The resulting seeds (10 % (v/v)) were added to 100 µM monomer and elongation 724 
measured in 20 mM Tris HCl, pH 7.5, containing 20 mM NaCl, 20 µM ThT at 37 °C using quiescent 725 
conditions.  726 
Negative stain TEM 727 
Samples at ThT incubation endpoints (usually 100 h) were diluted 1 in 10 or 1 in 5 with 18 Mɏ H2O 728 
and then applied to carbon coated copper grids in a dropwise fashion. Grids were then dried with 729 
filter paper, washed three times with 18 Mɏ H2O in a dropwise fashion, drying with filter paper after 730 
each wash, before fibril samples were negatively stained by the addition of 1% (w/v) uranyl acetate, 731 
added and blotted twice as before. Images were recorded on a Joel JEM-1400 or FEI Tecnai T12 732 
electron microscope.  733 
Preparation of disulfide locked dimeric ɲSyn species 734 
To allow the formation of disulfide linkages between monomeric ɲSyn Cys variants, 400 ʅM ɲSyn 735 
was incubated in 100 mM, Tris HCl, pH 8.4 for 2 h at room temperature. Protein samples were then 736 
added to a HiLoadTM 26/60 Superdex 75 preparative grade gel filtration column (GE Healthcare) in 737 
50 mM ammonium bicarbonate, pH 8.0, which allowed monomer and dimers to be resolved. 738 
Disulfide locked dimeric ɲSyn was then lyophilised and stored at -20 oC. The presence of disulfide 739 
linkages was validated using reducing and non-reducing SDS-PAGE with SEC-MALS used to validate 740 
the purification of dimeric constructs. For the latter, 50 ʅL of a 30 ʅM sample of αSyn was injected 741 
onto a TOSOH G200SWXL column equilibrated with 20 mM Tris HCl, containing 200 mM NaCl, pH 742 
7.5. The protein peak was eluted into a Wyatt miniDawnTreos system with three angle detection and 743 




NMR Backbone assignments of WT ɲSyn, ɲSyn P1P2-GS and ɲSyn ȴȴ 746 
WT and ȴȴ ɲSyn variants were 13C/15N uniformly labelled for NMR backbone assignments purposes. 747 
200 ʅM of protein in 20 mM sodium acetate, 20mM NaCl, 10% (v/v) D2O, 0.02% (w/v) sodium azide, 748 
pH 4.5 at 15 oC was used to acquire triple correlation experiments: HNCO, HNcaCO, HNCACB, 749 
HNcoCACB, HNN-TOCSY, hNcaNNH and hNcaNNH. All experiments were acquired using non-uniform 750 
sampling, where just 45% of sparse data was recorded on a Bruker AVANCE III 750 MHz 751 
spectrometer equipped with a triple resonance TCI-cryoprobe.  752 
NMR data processing and spectra reconstruction were performed using NMRpipe72 and data analysis 753 
with ccpNMR-Analysis software73. HN, Cα and Cβ chemical shifts were deposited at Biological 754 
Magnetic Resonance Bank (BMRB) with access numbers 27900, 27901 and 28045 for WT ɲSyn, ȴȴ 755 
and P1P2-GS, respectively.  756 
Paramagnetic Relaxation Enhancement NMR experiments 757 
ɲSyn Cys variants were incubated with 5 mM DTT in 20 mM Tris HCl, 200 mM NaCl, pH 7.5 for 30 758 
min. DTT was then removed by a Zeba spin column (PD10 column, GE Healthcare) and the sample 759 
labelled immediately by incubation with a 40-fold molar excess MTSL for 16 h at 4 oC in 20 mM Tris 760 
HCl, 200 mM NaCl, pH 7.5. Excess spin label was removed by Zeba spin column (PD10 column) and 761 
protein eluted in the required buffer. Spin-labelled ɲSyn constructs were used directly or stored at -762 
80 oC. In all cases 100 % labelling at a single site was confirmed using ESI-MS. For intramolecular PRE 763 
experiments, 1H-15N HSQC spectra were obtained using 100 ʅM 15N spin labelled ɲSyn in 20 mM 764 
acetate buffer pH 4.5 containing 20 mM or 200 mM NaCl, 10% (v/v) D2O, 0.02% (w/v) sodium azide 765 
on an AVANCE III Bruker spectrometer (600 MHz) equipped with a triple channel QCI-P cryoprobe. 766 
All NMR experiments were carried out at 15 oC. Diamagnetic spectra were obtained following the 767 
addition of 2 mM ascorbic acid. Note that small changes in chemical shift occur upon adding this acid 768 
to the protein spectra and reduction was not complete, leading to small residual intensity of some 769 
resonances in the spectra especially when MTSL was added to A90C (see legend to Extended Data 770 
Figure 4). Note that this does not affect the conclusions drawn since it underestimates, rather than 771 
overestimates the magnitude of the PRE measured. Spectra were processed in Topspin (Bruker) 772 
using CCPN74. Peak heights were used to calculate intensity ratios (paramagnetic/ diamagnetic). 773 
Control experiments in which 50 µM 15N αSyn and 14N αSyn-MTSL were mixed showed no PREs, 774 
ruling out intermolecular interactions at this protein concentration under the conditions used. PRE 775 
effects arising from non-specific binding of the hydrophobic probe MTSL to αSyn was ruled out by 776 
performing experiments in which 100 µM free MTSL was added to 100 µM 15N ɲSyn WT (lacking Cys) 777 
in which no PREs were observed. Replicate measurements of the PRE intensity ratios (I/I0) using 778 
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different preparations of WT αSyn in high and low salt conditions enabled per-reside errors to be 779 
determined. On average these were +/- 0.05. These data are available in 780 
(https://doi.org/10.5518/707). Intermolecular PRE experiments were carried out by mixing 250 ʅM 781 
15N WT or ȴȴ ɲSyn with 250 ʅM 14N-MTSL labelled protein. T2 transverse relaxation experiment was 782 
performed based in HSQC pulse sequence75 with 10 T2 delays (from 16.96 to 610.56 ms), under 783 
paramagnetic and diamagnetic conditions. Data processing was performed using NMRpipe72. Cross 784 
peaks intensities at each T2-delay were analysed using PINT and fitted to a single exponential decay 785 
using PINT. The effective HN-ȳ2 rate was calculated as the difference between the R2 rate in the 786 
paramagnetic versus the diamagnetic samples (Equation 1): 787 
 康 噺 迎態┸椎銚追銚 伐 迎態┸鳥沈銚  Eq. 1
Maintenance and generation of transgenic C. elegans strains and in vivo aggregation 788 
measurements 789 
The WT αSyn gene used was fused C-terminally to YFP in vector pPD30.3834. This vector was 790 
modified to delete amino acids 36-42 (ΔP1) or residues 36-42 and 45-57 (ΔΔ) by PCR mutagenesis. 791 
Transgenic C. elegans expressing each construct were then generated by microinjection of 792 
ΔP1αSyn::YFP or ΔΔαSyn::YFP constructs into the germline of N2 nematodes, resulting in strains 793 
PVH214 pccEx021[unc-54p::a-synuclein ΔP1::YFP] and PVH198 pccEx001[unc-54p::a-synuclein 794 
ΔP1ΔP2::YFP] (Nemametrix). Nematodes expressing WTαsyn::YFP were created using gene 795 
bombardment and kindly provided by Ellen Nollen34. 796 
For imaging, C. elegans was cultured on NGM plates seeded with E. coli OP50-1 at 20 oC as described 797 
previously76. C. elegans was imaged using a Zeiss LSM880 confocal fluorescent microscope through a 798 
10x 1.0 or a 20x 1.0 numerical aperture objective with a 514 nm line for excitation of YFP. Before 799 
imaging, age-synchronised animals at different ages (Day 0 (L4 stage) to Day 13) were anesthetised 800 
using 5 mM Levamisole solution in M9 buffer and mounted on 2% (w/v) agar pads. The number of 801 
ɲSyn::YFP foci were then counted and the mobility of all foci in at least 10 animals per time point 802 
and in three independent cultures of C. elegans (biological replicates) was determined using FRAP, as 803 
described previously34. Note that the higher expression levels of the ΔP1 and ΔΔ constructs does not 804 
affect the FRAP analysis, as FRAP measures relative fluorescence intensities of similar size photo-805 
bleached and unbleached regions within the same animal. 806 
To determine motility of the worms, a total of 30 age-synchronised animals were used for each assay 807 
and each experiment was repeated at least three times. Animals were moved into M9 buffer at 808 
indicated time points (Day 0 through to Day 13 of adulthood) and thrashing rates were measured by 809 
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counting body bends for 15 s using the wrMTrck plugin for ImageJ (available at 810 
http://www.phage.dk/plugins/wrmtrck.html)77. Error bars represent SEM of three biological 811 
replicates.  812 
Immunoblotting  813 
Nematodes were collected from plates, washed in M9 buffer, and resuspended in lysis buffer (20 814 
mM Tris HCl, pH 7.5; 10 mM ß-mercaptoethanol; 0.5% (v/v) Triton X-100; supplemented with 815 
complete protease inhibitor (Roche) before shock freezing in liquid nitrogen. Three freeze-thaw 816 
cycles were performed before the worm pellet was ground with a motorized pestle, and lysed on ice, 817 
in the presence of 0.025 U/mL benzonase (Sigma). The lysate was centrifuged at 1000 rpm for 1 min 818 
in a table top centrifuge to pellet the carcasses. Protein concentration was determined using 819 
Bradford assay (Bio-Rad). Samples were then mixed 1:1 with SDS loading buffer (2% (w/v) SDS, 10 % 820 
(v/v) glycerol, 0.1 % (w/v) bromophenol blue, 100 mM DTT), boiled for 10 min and 25 ʅg final 821 
protein was loaded onto a 4-20% gradient Tris HCl gel (Bio-Rad). Protein bands were blotted onto a 822 
PVDF membrane and ɲSyn and tubulin (control) were visualised using a mouse anti-αSyn antibody 823 
(syn211 (1:5000) (NeoMarkers)) or mouse anti-tubulin antibody (1:5000) (Sigma), followed by an 824 
anti-mouse horse-radish peroxidase-coupled secondary antibody (1:5000). Bands were visualised 825 
using the SuperSignal West Pico Plus Chemiluminescence Substrate (Thermo). 826 
Liposome preparation 827 
1,2-dimyristoyl-sn-glycero-3-phospho-L-serine (DMPS) (sodium salt, Avanti Polar Lipids) was 828 
dissolved in 20 mM sodium phosphate buffer, pH 6.5 and stirred at 45 °C for 2 h. The solution was 829 
then frozen and thawed 5-times using dry ice and a water bath at 45 °C, respectively. Preparation of 830 
liposomes was then carried out by sonication in a bath sonicator (U50 ultrasonic bath, Ultrawave) for 831 
1 h. The sizes of liposomes were measured using dynamic light scattering (DLS). For DLS 250 ʅL of 832 
100 ʅM samples were injected into a Wyatt miniDawnTreos system (equipped with an additional 833 
DLS detector) and the data analysed using Astra 6.0.3® software supplied with the instrument. 834 
Filtered (0.22 ʅm) and de-gassed buffer, kept cool on ice to minimise bubble formation inside the 835 
instrument, was used to obtain 5 min baselines before and after sample injection. A 3 min sample 836 
window was used for the analysis by the software. Using this analysis the liposomes were found to 837 
have a diameter у 160 nm.  838 
CD spectroscopy and lipid binding experiments 839 
CD samples were prepared by incubating 25 ʅM WT ɲSyn, ȴȴ or P1P2-GS with different 840 
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concentrations of DMPS liposomes in 20 mM sodium phosphate buffer, pH 6.5. Far-UV CD spectra 841 
were acquired in in 1 mm path length quartz cuvettes (Hellma) using a ChirascanTM plus CD 842 
Spectrometer (Applied Photophysics). CD spectra were acquired using a 2 nm bandwidth, 1 s time 843 
step, data collected at 1 nm increments at 30 oC. An average of 3 scans (190-260 nm) were acquired 844 
per sample. The data were fitted to determine the secondary structure content using Dichroweb78. 845 
KD and stoichiometry values were calculated from CD data using the protocol described in
61 using the 846 
fitting function shown in Equation 2: 847 
x喋 噺 蛮磐岷Syn峅 髪	
岷DMPS峅詣 髪 計帖卑 伐 俵峭磐岷Syn峅 髪 岷DMPS峅詣 髪	計帖卑態 伐	ね岷DMPS峅岷Syn峅詣 嶌	妃に岷Syn峅  
Eq. 2 
where XB is the fraction of ɲSyn bound to the membrane, L represents the number of DMPS 848 
molecules interacting with one molecule of ɲ-Syn and can be described as: 849 
  850 
 岷経警鶏鯨峅 噺 詣岫岷経警鶏鯨挑峅 髪 岷稽岫経警鶏鯨挑岻峅岻                                                                                                Eq. 3 851 
where B is the amount of ɲSyn bound to liposomes and L is the number of DMPS molecules 852 
interacting with one molecule of ɲ-Syn.   853 
NMR experiments to monitor liposome binding 854 
1H-15N HSQC NMR spectra were obtained using 25 µM 15N WT αSyn, P1P2-GS or ΔΔ αSyn in the 855 
absence or presence of 60:1 [DMPS]:[ɲSyn] ratios. Experiments were carried out in 20 mM sodium 856 
phosphate, pH 6.5 (as in61) containing 10% (v/v) D2O, 0.02% (w/v) sodium azide on an AVANCE III 857 
Bruker spectrometer (600 MHz) equipped with a cryogenic probe. All NMR experiments were carried 858 
out at 20 oC. Published assignments were used to analyse the data (BMRB 16543)58. Spectra were 859 
processed in Topspin (Bruker) and analysed in CCPN. Peak heights were used to calculate intensity 860 
ratios of αSyn in the presence versus in the absence of liposomes. 861 
Further information on experimental design is available in the Nature Research Reporting Summary 862 
linked to this article 863 
Data availability 864 
Chemical shift assignments can be accessed using BMRB numbers 27900 (WT-ɲSyn), 27901 (ȴȴ 865 
ɲSyn) and 28045 (P1P2-GS ɲSyn). Source data for Figure 1c-e, Figure 2a-d, Figure 3a-c, Figure4a-g, 866 
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Figure 5a-g. Figure 6b,d, Figure 7a-f and Figure 8d and Extended Figure 1a-h, Extended Figure 2a, 867 
Extended Figure 3b-g, Extended Figure 5a,b, Extended Figure6b,c and Extended Figure 7a-d are 868 
available with the paper online. Other datasets generated during and/or analysed during the current 869 
study are available in the University of Leeds data repository (https://doi.org/10.5518/707).  870 
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